JPMorgan Chase & Co’s LogicBio Therapeutics, Inc. Common Stock LOGC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-24
| Closed | – | – | 6262 |
|
|
2022
Q3 | $0 | Buy |
+24
| New | – | ﹤0.01% | 6065 |
|
|
2022
Q1 | – | Sell |
-344
| Closed | -$1K | – | 6165 |
|
|
2021
Q4 | $1K | Buy |
+344
| New | +$1K | ﹤0.01% | 5671 |
|
|
2021
Q3 | – | Sell |
-57,286
| Closed | -$254K | – | 5898 |
|
|
2021
Q2 | $254K | Sell |
57,286
-184,513
| -76% | -$818K | ﹤0.01% | 4371 |
|
|
2021
Q1 | $1.76M | Sell |
241,799
-44,495
| -16% | -$324K | ﹤0.01% | 3315 |
|
|
2020
Q4 | $2.18M | Sell |
286,294
-21,313
| -7% | -$163K | ﹤0.01% | 2913 |
|
|
2020
Q3 | $2.91M | Sell |
307,607
-41,801
| -12% | -$395K | ﹤0.01% | 2548 |
|
|
2020
Q2 | $2.96M | Sell |
349,408
-58,513
| -14% | -$495K | ﹤0.01% | 2479 |
|
|
2020
Q1 | $2.01M | Buy |
407,921
+393,304
| +2,691% | +$1.94M | ﹤0.01% | 2589 |
|
|
2019
Q4 | $105K | Buy |
14,617
+11,925
| +443% | +$85.7K | ﹤0.01% | 4003 |
|
|
2019
Q3 | $29K | Buy |
2,692
+396
| +17% | +$4.27K | ﹤0.01% | 4406 |
|
|
2019
Q2 | $28K | Buy |
2,296
+314
| +16% | +$3.83K | ﹤0.01% | 4456 |
|
|
2019
Q1 | $20K | Sell |
1,982
-463
| -19% | -$4.67K | ﹤0.01% | 4509 |
|
|
2018
Q4 | $26K | Buy |
+2,445
| New | +$26K | ﹤0.01% | 4451 |
|